Skip to main content
Erschienen in:

28.01.2025 | Original Research Article

Regular Use of Oral Nonsteroidal Anti-inflammatory Drugs in a Population of Polish Seniors: Findings from the PolSenior2 Cross-Sectional Survey

verfasst von: Karol Wierzba, Michał Chmielewski, Emilia Błeszyńska-Marunowska, Kacper Jagiełło, Łukasz Wierucki, Tomasz Zdrojewski

Erschienen in: Drugs & Aging | Ausgabe 3/2025

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Older adults represent a growing proportion of the general population. Nonsteroidal anti-inflammatory drugs (NSAIDs) constitute a group of medicines that are both necessary, owing to their anti-inflammatory, analgesic, and cardioprotective abilities, and potentially harmful, owing to their side effects.

Objectives

This study provides a comprehensive analysis of NSAID usage patterns among Polish adults aged 60 years and older. It focused on the regular use (≥ three times per week) of two types of NSAIDs: acetylsalicylic acid (ASA) and non-ASA NSAIDs, examining consumption on the basis of age, sex, educational level, and place of residence.

Methods

Data were collected from the PolSenior2 study, a national cross-sectional survey of 5987 Polish individuals aged 60–106 years, conducted from 2018 to 2019.

Results

The study found that 30.7% [95% confidence interval (CI) 28.8–32.7)]of Polish seniors regularly used NSAIDs, with 26.2% (95% CI 24.5–28.0) regularly using ASA, 6.3% (95% CI 5.3–7.2) regularly using non-ASA NSAIDs, and 1.9% (95% CI 1.4–2.3) reporting regular use of both. An age-related increase in regular NSAID use, including ASA, was observed. Women were more likely than men to use non-ASA NSAIDs regularly, whereas men in the 70–79 age group were more likely to use ASA. A lower level of education was associated with more frequent NSAID use.

Conclusions

The findings have implications for healthcare practitioners and policymakers, emphasizing the need for careful management of NSAID use. The study contributes to a more nuanced understanding of NSAID usage and underscores the necessity for tailored healthcare strategies to ensure safe and effective medication use among older adults.
Literatur
1.
Zurück zum Zitat European Commission. Statistical Office of the European Union. Ageing Europe: looking at the lives of older people in the EU : 2020 edition. LU: Publications Office; 2020. European Commission. Statistical Office of the European Union. Ageing Europe: looking at the lives of older people in the EU : 2020 edition. LU: Publications Office; 2020.
2.
Zurück zum Zitat Cadet C, Maheu E, The French AGRHUM Group (Association Geriatric and RHeUMatology). Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe? Ther Adv Musculoskelet Dis. 2021;13:1759720X2110221. https://doi.org/10.1177/1759720X211022149.CrossRef Cadet C, Maheu E, The French AGRHUM Group (Association Geriatric and RHeUMatology). Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe? Ther Adv Musculoskelet Dis. 2021;13:1759720X2110221. https://​doi.​org/​10.​1177/​1759720X21102214​9.CrossRef
6.
Zurück zum Zitat By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;2023(71):2052–81. https://doi.org/10.1111/jgs.18372.CrossRef By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;2023(71):2052–81. https://​doi.​org/​10.​1111/​jgs.​18372.CrossRef
17.
Zurück zum Zitat Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64:465–74. https://doi.org/10.1002/acr.21596.CrossRef Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64:465–74. https://​doi.​org/​10.​1002/​acr.​21596.CrossRef
18.
Zurück zum Zitat Chan FKL, Abraham NS, Scheiman JM, Laine L, for the First International Working Party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents*. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the first international working party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents. Am J Gastroenterol. 2008;103:2908–18. https://doi.org/10.1111/j.1572-0241.2008.02200.x.CrossRefPubMed Chan FKL, Abraham NS, Scheiman JM, Laine L, for the First International Working Party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents*. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the first international working party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents. Am J Gastroenterol. 2008;103:2908–18. https://​doi.​org/​10.​1111/​j.​1572-0241.​2008.​02200.​x.CrossRefPubMed
25.
30.
Zurück zum Zitat Błędowski P, Grodzicki T, Mossakowska M, Zdrojewski T, editors. A study on individual components of the health condition in the elderly, including health‑related quality of life [Polish]. Gdańsk: Gdański Uniwersytet Medyczny; 2021. Błędowski P, Grodzicki T, Mossakowska M, Zdrojewski T, editors. A study on individual components of the health condition in the elderly, including health‑related quality of life [Polish]. Gdańsk: Gdański Uniwersytet Medyczny; 2021.
32.
35.
Zurück zum Zitat Zeng C, Wei J, Persson MSM, Sarmanova A, Doherty M, Xie D, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52:642–50. https://doi.org/10.1136/bjsports-2017-098043.CrossRefPubMed Zeng C, Wei J, Persson MSM, Sarmanova A, Doherty M, Xie D, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52:642–50. https://​doi.​org/​10.​1136/​bjsports-2017-098043.CrossRefPubMed
37.
Zurück zum Zitat Demographic Yearbook of Poland 2023. Demographic Yearbook of Poland. 2023. Demographic Yearbook of Poland 2023. Demographic Yearbook of Poland. 2023.
46.
Zurück zum Zitat Pstrągowski MT, Bujalska-Zadrożny M, Filipiak KJ. Pacjenci nabywający kwas acetylosalicylowy w polskich aptekach—charakterystyka populacji, opis problemu medycznego. Folia Cardiol. 2015;10:158–63. Pstrągowski MT, Bujalska-Zadrożny M, Filipiak KJ. Pacjenci nabywający kwas acetylosalicylowy w polskich aptekach—charakterystyka populacji, opis problemu medycznego. Folia Cardiol. 2015;10:158–63.
54.
Metadaten
Titel
Regular Use of Oral Nonsteroidal Anti-inflammatory Drugs in a Population of Polish Seniors: Findings from the PolSenior2 Cross-Sectional Survey
verfasst von
Karol Wierzba
Michał Chmielewski
Emilia Błeszyńska-Marunowska
Kacper Jagiełło
Łukasz Wierucki
Tomasz Zdrojewski
Publikationsdatum
28.01.2025
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 3/2025
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-025-01180-x

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

RA-Basistherapie: Neues zu altbekannten Medikamenten

Zu glauben, zur Basistherapie der rheumatoiden Arthritis (RA) mit Methotrexat und Glukokortikoiden sei bereits alles gesagt, hat sich beim diesjährigen Rheuma-Update-Seminar wieder einmal als falsch erwiesen. Sogar eine in der Praxis „viel geübte Strategie“ wurde hinterfragt.

Erhöhte Hypoglykämie-Gefahr nach Beginn einer Betablockertherapie

Beginnen Diabetiker eine Behandlung mit Betablockern, verdoppelt sich in den ersten Wochen fast das Hypoglykämie-Risiko, normalisiert sich mit der Zeit aber wieder. Besondere Vorsicht ist unter einer Therapie mit nichtselektiven Wirkstoffen geboten.

Nierenzellkarzinom: Daten zur Lebensqualität unter HIF-Inhibition vorgelegt

Seit wenigen Wochen ist mit Belzutifan eine neue Wirkstoffklasse beim fortgeschrittenen klarzelligen Nierenzellkarzinom in der EU zugelassen. Frisch publizierte Ergebnisse zur Lebensqualität erweitern jetzt die Datenbasis zur Risiko-Nutzen-Bewertung für den HIF-2α-Inhibitor.

Warum genderspezifische Medizin notwendig ist 

Laut Zahlen der WHO aus dem Jahr 2024 sterben zwei Frauen pro Minute an Krankheiten, die mit geschlechtsspezifischen Faktoren zusammenhängen. Außerdem wirken Medikamente bei ihnen oft anders als bei Männern. Zeit für ein genderspezifisches Denken in der Medizin.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.